Pine Ridge Advisers’s Roivant Sciences ROIV Stock Holding History

Pine Ridge Advisers’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.79M	Hold	276,530	–	–	0.59%	26
2026 Q1	$7.66M	Hold	276,530	–	–	0.47%	23
2025 Q4	$6M	Hold	276,530	–	–	0.36%	27
2025 Q3	$4.18M	Hold	276,530	–	–	0.25%	27
2025 Q2	$3.12M	Hold	276,530	–	–	0.2%	33
2025 Q1	$2.79M	Hold	276,530	–	–	0.24%	29
2024 Q4	$3.27M	Hold	276,530	–	–	0.29%	27
2024 Q3	$3.19M	Hold	276,530	–	–	0.32%	28
2024 Q2	$2.92M	Buy	+276,530	New	+$3.03M	0.31%	26

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Pine Ridge Advisers's ROIV Position: Q2 2026 in Review

Pine Ridge Advisers held its Roivant Sciences (ROIV) position steady in Q2 2026 at 276,530 shares worth $9.79M. The position accounts for 0.59% of the portfolio, ranked #26.

Pine Ridge Advisers first reported a position in ROIV in Q2 2024 and has held it in 9 quarters since. 500 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Pine Ridge Advisers held 276,530 shares of Roivant Sciences worth $9.79M as of Q2 2026.
Pine Ridge Advisers left its Roivant Sciences share count unchanged in Q2 2026.
Roivant Sciences made up 0.59% of Pine Ridge Advisers's portfolio in Q2 2026, its #26 holding.
Pine Ridge Advisers first reported a position in Roivant Sciences in Q2 2024 and has held it in 9 quarters since.
500 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Pine Ridge Advisers's 13F filing for Q2 2026, filed 14 Aug 2026.